Skip navigation
BelSU DSpace logo

Browsing by Subject pharmacology

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
or enter first few letters:  
Showing results 151 to 170 of 422 < previous   next >
Issue DateTitleAuthor(s)
2022Genetically modified animal models of hereditary diseases for testing of gene-directed therapyPolikarpova, A. V.; Egorova, T. V.; Bardina, M. V.
2021Genetically modified animals for use in bio‑pharmacology: from research to productionDeykin, A. V.; Shcheblykina, O. V.; Povetka, E. E.; Golubinskaya, P. A.; Pokrovsky, V. M.
2022Harmine and 7,8-dihydroxyflavone synergistically suitable for amyotrophic lateral sclerosis management: An in silico studyToluwase Fatoki; Stanley Chukwuejim; Omodele Ibraheem; Christiana Oke; Blessing Ejimadu
2019Hepatoprotective effect of opioid peptides in stressSolin, A. V.; Lyashev, Y. D.; Tsygan, N. V.
2021High performance liquid chromatography method for determination of carnosine and taurine and composition them with Fe₃O₄ nanoparticlesFadeeva, D. A.; Zhilyakova, E. T.; Malyutina, A. Yu.; Kazakova, V. S.; Avtina, N. V.; Timoshenko, E. Yu.
2015Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injuryAlehin, S. A.; Kolmykov, D. I.; Pokrovskii, M. V.
2024Identification and synthesis of metabolites of the new antiglaucoma drugKhokhlov, A. L.; Yaichkov, I. I.; Korsakov, M. K.; Shetnev, A. A.; Ivanovskiy, S. A.
2018Imidazoline receptors agonists: possible mechanisms of endothelioprotectionSoldatov, V. O.; Shmykova, E. A.; Pershina, M. A.; Ksenofontov, A. O.; Zamitsky, Y. M.
2019Immune-metabolic genesis of pathological processesZemskov, A. M.; Berezhnova, T. A.; Zemskova, V. A.; Dyadina, K. S.; Kulintsova, Y. V.
2020Immune-metabolic therapy of purulent inflammatory diseasesBerezhnova, T. A.; Dyadina, K. S.; Kulintsova, Ya. V.
2018Immunotherapy in the treatment of chronic cystitisKulintsova, Ya. V.; Zemskov, A. M.; Berezhnova, T. A.
2023Impact of COVID-19 on clinical trials protocol amendmentsEleskina, A. A.; Pyatigorskaya, N. V.; Filippova, O. V.
2021Impact of organotin compounds on the growth of epidermoid Lewis carcinomaDodokhova, M. A.; Safronenko, A. V.; Kotieva, I. M.; Alkhuseyn-Kulyaginova, M. S.; Shpakovsky, D. B.
2023Improving antitumor targeting via using PL3 homing peptide and cell-penetrating peptideDhafir Masheta; Shafq Al-azzawi
2021In search of new brain biomarkers of stressShabanov, P. D.; Blazhenko, A. A.; Devyashin, A. S.; Khokhlov, P. P.; Lebedev, A. A.
2022In silico identification of the potential natural inhibitors of SARS-CoV-2 Guanine-N7 methyltransferaseRowaiye, A. B.; Onuh, O. A.; Oladimeji-Salami, J. A.; Doofan Bur; Moses Njoku
2021In vivo study of pharmacokinetic parameters of a new combination drug based on citicoline and memantineSysuev, B. B.; Salakhetdinov, D. K.
2022In-silico identification of novel inhibitors for human Aurora kinase B form the ZINC database using molecular docking-based virtual screeningAshraf Ahmed Ali Abdusalam
2019Influence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularizationAskari, I. V.; Osipova, O. A.
2020Influence of Diazepino [1,2-a] benzimidazole derivative (DAB-19) on behavioral aspects of animalsMaltsev, D. V.; Spasov, A. A.; Miroshnikov, M. V.; Skripka, M. O.; Divaeva, L. N.